RESUMEN
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease. While ≈50% of patients with HCM carry a sarcomere gene mutation (sarcomere mutation-positive, HCMSMP), the genetic background is unknown in the other half of the patients (sarcomere mutation-negative, HCMSMN). Genotype-specific differences have been reported in cardiac function. Moreover, HCMSMN patients have later disease onset and a better prognosis than HCMSMP patients. To define if genotype-specific derailments at the protein level may explain the heterogeneity in disease development, we performed a proteomic analysis in cardiac tissue from a clinically well-phenotyped HCM patient group. METHODS: A proteomics screen was performed in cardiac tissue from 39 HCMSMP patients, 11HCMSMN patients, and 8 nonfailing controls. Patients with HCM had obstructive cardiomyopathy with left ventricular outflow tract obstruction and diastolic dysfunction. A novel MYBPC32373insG mouse model was used to confirm functional relevance of our proteomic findings. RESULTS: In all HCM patient samples, we found lower levels of metabolic pathway proteins and higher levels of extracellular matrix proteins. Levels of total and detyrosinated α-tubulin were markedly higher in HCMSMP than in HCMSMN and controls. Higher tubulin detyrosination was also found in 2 unrelated MYBPC3 mouse models and its inhibition with parthenolide normalized contraction and relaxation time of isolated cardiomyocytes. CONCLUSIONS: Our findings indicate that microtubules and especially its detyrosination contribute to the pathomechanism of patients with HCMSMP. This is of clinical importance since it represents a potential treatment target to improve cardiac function in patients with HCMSMP, whereas a beneficial effect may be limited in patients with HCMSMN.
Asunto(s)
Cardiomiopatía Hipertrófica/metabolismo , Tubulina (Proteína)/metabolismo , Tirosina/metabolismo , Obstrucción del Flujo Ventricular Externo/metabolismo , Adulto , Anciano , Animales , Miosinas Cardíacas/genética , Cardiomiopatía Hipertrófica/genética , Cardiomiopatía Hipertrófica/fisiopatología , Proteínas Portadoras/genética , Estudios de Casos y Controles , Modelos Animales de Enfermedad , Femenino , Haploinsuficiencia , Humanos , Masculino , Persona de Mediana Edad , Cadenas Pesadas de Miosina/genética , Proteómica , Sarcómeros/genética , Troponina I/genética , Troponina T/genética , Obstrucción del Flujo Ventricular Externo/genética , Obstrucción del Flujo Ventricular Externo/fisiopatología , Tabique Interventricular/metabolismoRESUMEN
Cardiac amyloid A (AA) amyloidosis is rare. We present the case of a 72-year-old woman with obstructive hypertrophic cardiomyopathy (HCM) and biopsy-proven renal AA amyloidosis whose dyspnea and exercise intolerance had worsened over the previous year. Her AA amyloidosis was suspected to be secondary to chronic diverticulitis for which she had undergone hemicolectomy and sigmoidectomy 3 years prior. Echocardiographic findings were consistent with worsening left ventricular outflow tract obstruction at rest. Cardiac magnetic resonance imaging revealed patchy areas of midwall late gadolinium enhancement. Right ventricular endomyocardial biopsy did not reveal amyloid deposition, and cardiac technetium-99m pyrophosphate scintigraphy did not suggest transthyretin amyloidosis. The patient underwent septal myectomy with resection of an accessory papillary muscle. Pathological examination of the myectomy specimen was consistent with HCM. In addition, there was a thick layer of diffuse endocardial and vascular amyloid deposition that was identified as AA type by laser-microdissection with liquid chromatography-coupled tandem-mass spectrometry. This case report highlights the presence of 2 distinct disease processes occurring simultaneously and the importance of tissue diagnosis of AA amyloidosis, a condition that is not commonly associated with HCM.
Asunto(s)
Amiloidosis/complicaciones , Cardiomiopatía Hipertrófica/complicaciones , Insuficiencia Cardíaca/etiología , Enfermedades Renales/complicaciones , Miocardio/patología , Obstrucción del Flujo Ventricular Externo/etiología , Anciano , Amiloidosis/metabolismo , Amiloidosis/patología , Amiloidosis/fisiopatología , Procedimientos Quirúrgicos Cardíacos , Cardiomiopatía Hipertrófica/metabolismo , Cardiomiopatía Hipertrófica/patología , Cardiomiopatía Hipertrófica/fisiopatología , Femenino , Insuficiencia Cardíaca/metabolismo , Insuficiencia Cardíaca/patología , Insuficiencia Cardíaca/fisiopatología , Humanos , Enfermedades Renales/metabolismo , Enfermedades Renales/patología , Miocardio/metabolismo , Proteína Amiloide A Sérica/metabolismo , Resultado del Tratamiento , Función Ventricular Izquierda , Obstrucción del Flujo Ventricular Externo/metabolismo , Obstrucción del Flujo Ventricular Externo/patología , Obstrucción del Flujo Ventricular Externo/fisiopatologíaRESUMEN
Dominant mutations of Gata4, an essential cardiogenic transcription factor (TF), were known to cause outflow tract (OFT) defects in both human and mouse, but the underlying molecular mechanism was not clear. In this study, Gata4 haploinsufficiency in mice was found to result in OFT defects including double outlet right ventricle (DORV) and ventricular septum defects (VSDs). Gata4 was shown to be required for Hedgehog (Hh)-receiving progenitors within the second heart field (SHF) for normal OFT alignment. Restored cell proliferation in the SHF by knocking-down Pten failed to rescue OFT defects, suggesting that additional cell events under Gata4 regulation is important. SHF Hh-receiving cells failed to migrate properly into the proximal OFT cushion, which is associated with abnormal EMT and cell proliferation in Gata4 haploinsufficiency. The genetic interaction of Hh signaling and Gata4 is further demonstrated to be important for OFT development. Gata4 and Smo double heterozygotes displayed more severe OFT abnormalities including persistent truncus arteriosus (PTA). Restoration of Hedgehog signaling renormalized SHF cell proliferation and migration, and rescued OFT defects in Gata4 haploinsufficiency. In addition, there was enhanced Gata6 expression in the SHF of the Gata4 heterozygotes. The Gata4-responsive repressive sites were identified within 1kbp upstream of the transcription start site of Gata6 by both ChIP-qPCR and luciferase reporter assay. These results suggested a SHF regulatory network comprising of Gata4, Gata6 and Hh-signaling for OFT development.
Asunto(s)
Factor de Transcripción GATA4/genética , Factor de Transcripción GATA6/genética , Proteínas Hedgehog/genética , Receptor Smoothened/genética , Obstrucción del Flujo Ventricular Externo/genética , Tabique Interventricular/metabolismo , Animales , Movimiento Celular , Proliferación Celular , Embrión de Mamíferos , Factor de Transcripción GATA4/metabolismo , Factor de Transcripción GATA6/metabolismo , Regulación de la Expresión Génica , Haploinsuficiencia , Proteínas Hedgehog/metabolismo , Heterocigoto , Humanos , Ratones , Ratones Transgénicos , Miocitos Cardíacos/metabolismo , Miocitos Cardíacos/patología , Transducción de Señal , Receptor Smoothened/metabolismo , Tronco Arterial/anomalías , Tronco Arterial/metabolismo , Obstrucción del Flujo Ventricular Externo/metabolismo , Obstrucción del Flujo Ventricular Externo/patología , Tabique Interventricular/patologíaRESUMEN
BACKGROUND: In infants with left-sided obstructive lesions (LSOL), the presence of retrograde blood flow in either the ascending or descending aorta may lead to diminished cerebral and renal blood flow, respectively. OBJECTIVES: Our aim was to compare cerebral and renal tissue oxygen saturation (rSO2) between infants with LSOL with antegrade and retrograde blood flow in the ascending aorta and with and without diastolic backflow in the descending aorta. METHODS: Based on 2 echocardiograms, the study group was categorized according to the direction of blood flow in the ascending and descending aorta. We measured cerebral and renal rSO2 using near-infrared spectroscopy and calculated fractional tissue oxygen extraction (FTOE). RESULTS: Nineteen infants with LSOL, admitted to the NICU between 0 and 28 days after birth, were included. Infants with antegrade blood flow (n = 12) and infants with retrograde blood flow in the ascending aorta (n = 7) had similar cerebral rSO2 and FTOE during both echocardiograms. Only during the first echocardiogram, infants with retrograde blood flow in the ascending aorta had lower renal FTOE (0.14 vs. 0.32, p = 0.04) and tended to have higher renal rSO2 (80 vs. 65%, p = 0.09). The presence of diastolic backflow in the descending aorta was not associated with cerebral or renal rSO2 and FTOE during the first (n = 8) as well as the second echocardiogram (n = 10). CONCLUSIONS: Retrograde blood flow in the ascending aorta was not associated with cerebral oxygenation, while diastolic backflow in the descending aorta was not associated with renal oxygenation in infants with LSOL.
Asunto(s)
Aorta Torácica/fisiopatología , Encéfalo/metabolismo , Circulación Cerebrovascular/fisiología , Riñón/irrigación sanguínea , Riñón/metabolismo , Oxígeno/metabolismo , Obstrucción del Flujo Ventricular Externo/fisiopatología , Aorta Torácica/anomalías , Encéfalo/irrigación sanguínea , Estudios de Cohortes , Femenino , Cardiopatías Congénitas/metabolismo , Cardiopatías Congénitas/fisiopatología , Hemodinámica , Humanos , Recién Nacido , Recien Nacido Prematuro , Masculino , Consumo de Oxígeno/fisiología , Flujo Sanguíneo Regional , Nacimiento a Término , Obstrucción del Flujo Ventricular Externo/metabolismoRESUMEN
BACKGROUND: The right ventricular outflow tract (RVOT) is acknowledged to be responsible for arrhythmogenesis in Brugada syndrome (BrS), but the pathophysiology remains controversial. OBJECTIVES: This study assessed the substrate underlying BrS at post-mortem and in vivo, and the role for open thoracotomy ablation. METHODS: Six whole hearts from male post-mortem cases of unexplained sudden death (mean age 23.2 years) with negative specialist cardiac autopsy and familial BrS were used and matched to 6 homograft control hearts by sex and age (within 3 years) by random risk set sampling. Cardiac autopsy sections from cases and control hearts were stained with picrosirius red for collagen. The RVOT was evaluated in detail, including immunofluorescent stain for connexin-43 (Cx43). Collagen and Cx43 were quantified digitally and compared. An in vivo study was undertaken on 6 consecutive BrS patients (mean age 39.8 years, all men) during epicardial RVOT ablation for arrhythmia via thoracotomy. Abnormal late and fractionated potentials indicative of slowed conduction were identified, and biopsies were taken before ablation. RESULTS: Collagen was increased in BrS autopsy cases compared with control hearts (odds ratio [OR]: 1.42; p = 0.026). Fibrosis was greatest in the RVOT (OR: 1.98; p = 0.003) and the epicardium (OR: 2.00; p = 0.001). The Cx43 signal was reduced in BrS RVOT (OR: 0.59; p = 0.001). Autopsy and in vivo RVOT samples identified epicardial and interstitial fibrosis. This was collocated with abnormal potentials in vivo that, when ablated, abolished the type 1 Brugada electrocardiogram without ventricular arrhythmia over 24.6 ± 9.7 months. CONCLUSIONS: BrS is associated with epicardial surface and interstitial fibrosis and reduced gap junction expression in the RVOT. This collocates to abnormal potentials, and their ablation abolishes the BrS phenotype and life-threatening arrhythmias. BrS is also associated with increased collagen throughout the heart. Abnormal myocardial structure and conduction are therefore responsible for BrS.
Asunto(s)
Síndrome de Brugada , Colágeno/metabolismo , Conexina 43/metabolismo , Muerte Súbita Cardíaca , Miocardio , Pericardio , Obstrucción del Flujo Ventricular Externo , Técnicas de Ablación/métodos , Adulto , Síndrome de Brugada/complicaciones , Síndrome de Brugada/diagnóstico , Síndrome de Brugada/cirugía , Muerte Súbita Cardíaca/etiología , Muerte Súbita Cardíaca/patología , Electrocardiografía , Fibrosis , Uniones Comunicantes/patología , Sistema de Conducción Cardíaco/metabolismo , Sistema de Conducción Cardíaco/patología , Humanos , Masculino , Miocardio/metabolismo , Miocardio/patología , Pericardio/metabolismo , Pericardio/patología , Toracotomía/métodos , Obstrucción del Flujo Ventricular Externo/etiología , Obstrucción del Flujo Ventricular Externo/metabolismo , Obstrucción del Flujo Ventricular Externo/patología , Obstrucción del Flujo Ventricular Externo/cirugíaAsunto(s)
Quinasa 2 del Receptor Acoplado a Proteína-G/metabolismo , Cardiopatías Congénitas/complicaciones , Miocitos Cardíacos/metabolismo , Receptores Adrenérgicos beta/metabolismo , Disfunción Ventricular Derecha/metabolismo , Función Ventricular Derecha/fisiología , Obstrucción del Flujo Ventricular Externo/metabolismo , Ecocardiografía , Estudios de Seguimiento , Atrios Cardíacos/metabolismo , Atrios Cardíacos/patología , Atrios Cardíacos/fisiopatología , Cardiopatías Congénitas/diagnóstico , Cardiopatías Congénitas/cirugía , Humanos , Miocitos Cardíacos/patología , Fosforilación , Disfunción Ventricular Derecha/etiología , Disfunción Ventricular Derecha/fisiopatología , Obstrucción del Flujo Ventricular Externo/etiología , Obstrucción del Flujo Ventricular Externo/fisiopatologíaRESUMEN
OBJECTIVE: Reduction of left ventricular outflow tract obstruction (LVOTO) often improves symptoms in hypertrophic cardiomyopathy (HCM), but the correlation between exercise performance and measured LVOT gradients is weak. We investigated the relationship between LVOTO and cardiorespiratory responses during exercise. METHODS: The study cohort included 70 patients with HCM (32 with LVOTO, 55 male, age 47±13) attending a dedicated cardiomyopathy clinic and 28 normal volunteers. All underwent cardiopulmonary exercise testing with simultaneous non-invasive haemodynamic assessment using finger plethysmography. Main outcome measures were peak oxygen consumption, cardiac index and arteriovenous oxygen difference. RESULTS: When compared with controls, patients had reduced peak exercise oxygen consumption (22.4±6.1 vs 34.7±7.7 mL/kg/min, p<0.0001) and cardiac index (5.5±1.9 vs 9.4±2.9 L/min/m(2), p<0.0001). At all workloads, stroke volume index (SVI) was lower and arteriovenous oxygen difference greater in patients. During all stages of exercise, LVOTO in patients was associated with failure to augment SVI and higher oxygen consumption; cardiac reserve (4.4±2.7 vs 6.3±3.6 L/min, p=0.025) and peak mean arterial pressure (104±16 vs 112±16 mm Hg, p=0.033) were lower. Multivariable predictors of cardiac output response were age (ß: -0.11; CI -0.162 to -0.057; p<0.0001), peak LVOT gradient (ß: -0.018; CI -0.034 to -0.002; p=0.031) and gender (ß: -2.286; CI -0.162 to -0.577; p=0.01). Within the obstructive cohort, different patterns of SV response were elicited in patients with similar clinical features. CONCLUSIONS: Cardiac reserve is reduced in HCM because of failure of SV augmentation. LVOTO exacerbates this abnormal response, but haemodynamic responses vary significantly. Non-invasive exercise haemodynamic assessment may improve understanding of symptoms and help tailor therapy.
Asunto(s)
Gasto Cardíaco , Cardiomiopatía Hipertrófica/complicaciones , Tolerancia al Ejercicio , Consumo de Oxígeno , Obstrucción del Flujo Ventricular Externo/etiología , Adaptación Fisiológica , Adulto , Presión Sanguínea , Cardiomiopatía Hipertrófica/diagnóstico , Cardiomiopatía Hipertrófica/metabolismo , Cardiomiopatía Hipertrófica/fisiopatología , Estudios de Casos y Controles , Prueba de Esfuerzo , Femenino , Frecuencia Cardíaca , Humanos , Modelos Lineales , Masculino , Persona de Mediana Edad , Análisis Multivariante , Pletismografía , Factores de Riesgo , Resistencia Vascular , Obstrucción del Flujo Ventricular Externo/diagnóstico , Obstrucción del Flujo Ventricular Externo/metabolismo , Obstrucción del Flujo Ventricular Externo/fisiopatologíaRESUMEN
Congenital heart disease (CHD) is a devastating anomaly that affects â¼1% of live births. Defects of the outflow tract (OFT) make up a large percentage of human CHD. We investigated Bmp signaling in mouse OFT development by conditionally deleting both Bmp4 and Bmp7 in the second heart field (SHF). SHF Bmp4/7 deficiency resulted in defective epithelial to mesenchymal transition (EMT) and reduced cardiac neural crest ingress, with resultant persistent truncus arteriosus. Using a candidate gene approach, we found that Vegfa was upregulated in the Bmp4/7 mutant hearts. To determine if Vegfa is a downstream Bmp effector during EMT, we examined whether Vegfa is transcriptionally regulated by the Bmp receptor-regulated Smad. Our findings indicate that Smad directly binds to Vegfa chromatin and represses Vegfa transcriptional activity. We also found that Vegfa is a direct target for the miR-17-92 cluster, which is also regulated by Bmp signaling in the SHF. Deletion of miR-17-92 reveals similar phenotypes to Bmp4/7 SHF deletion. To directly address the function of Vegfa repression in Bmp-mediated EMT, we performed ex vivo explant cultures from Bmp4/7 and miR-17-92 mutant hearts. EMT was defective in explants from the Bmp4/7 double conditional knockout (dCKO; Mef2c-Cre;Bmp4/7(f/f)) and miR-17-92 null. By antagonizing Vegfa activity in explants, EMT was rescued in Bmp4/7 dCKO and miR-17-92 null culture. Moreover, overexpression of miR-17-92 partially suppressed the EMT defect in Bmp4/7 mutant embryos. Our study reveals that Vegfa levels in the OFT are tightly controlled by Smad- and microRNA-dependent pathways to modulate OFT development.
Asunto(s)
Proteína Morfogenética Ósea 4/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismo , Obstrucción del Flujo Ventricular Externo/patología , Animales , Secuencia de Bases , Proteína Morfogenética Ósea 4/genética , Proteína Morfogenética Ósea 7/genética , Proteína Morfogenética Ósea 7/metabolismo , Células Cultivadas , Embrión de Mamíferos/metabolismo , Transición Epitelial-Mesenquimal , Regulación del Desarrollo de la Expresión Génica , Ratones , Ratones Noqueados , MicroARNs/genética , MicroARNs/metabolismo , Datos de Secuencia Molecular , Mutación , Miocardio/metabolismo , Miocardio/patología , Regiones Promotoras Genéticas , Proteínas Represoras/genética , Proteínas Represoras/metabolismo , Transducción de Señal , Proteína Smad1/genética , Proteína Smad1/metabolismo , Transcripción Genética , Tronco Arterial Persistente/metabolismo , Tronco Arterial Persistente/patología , Factor A de Crecimiento Endotelial Vascular/genética , Obstrucción del Flujo Ventricular Externo/metabolismoRESUMEN
Tetralogy of Fallot (TOF) is a congenital heart condition in which the right ventricle is exposed to cyanosis and pressure overload. Patients have an increased risk of right ventricle dysfunction following corrective surgery. Whether the cyanotic myocardium is less tolerant of injury compared to non-cyanotic is unclear. Heat shock proteins (HSPs) protect against cellular stresses. The aim of this study was to examine HSP 27 expression in the right ventricle resected from TOF patients and determine its relationship with right ventricle function and clinical outcome. Ten cyanotic and ten non-cyanotic patients were studied. Western blotting was used to quantify HSP 27 in resected myocardium at (1) baseline (first 15 min of aortic cross clamp and closest representation of pre-operative status) and (2) after 15 min during ischemia until surgery was complete. The cyanotic group had significantly increased haematocrit, lower O2 saturation, thicker interventricular septal wall thickness and released more troponin-I on post-operative day 1 (p < 0.05). HSP 27 expression was significantly increased in the < 15 min cyanotic compared to the < 15 min non-cyanotic group (p = 0.03). In the cyanotic group, baseline HSP 27 expression also significantly correlated with oxygen extraction ratio (p = 0.028), post-operative basal septal velocity (p = 0.036) and mixed venous oxygen saturation (p = 0.02), markers of improved cardiac output/contraction. Increased HSP 27 expression and associated improved right ventricle function and systemic perfusion supports a cardio-protective effect of HSP 27 in cyanotic TOF.
Asunto(s)
Gasto Cardíaco/fisiología , Cianosis/metabolismo , Proteínas de Choque Térmico HSP27/metabolismo , Contracción Miocárdica/fisiología , Miocardio/patología , Tetralogía de Fallot/metabolismo , Tetralogía de Fallot/fisiopatología , Western Blotting , Cianosis/complicaciones , Cianosis/fisiopatología , Cianosis/cirugía , Femenino , Proteínas de Choque Térmico , Humanos , Lactante , Masculino , Chaperonas Moleculares , Miocardio/metabolismo , Oxígeno/metabolismo , Cuidados Posoperatorios , Tetralogía de Fallot/complicaciones , Tetralogía de Fallot/cirugía , Troponina I/metabolismo , Obstrucción del Flujo Ventricular Externo/metabolismo , Obstrucción del Flujo Ventricular Externo/fisiopatología , Obstrucción del Flujo Ventricular Externo/cirugíaRESUMEN
Patients with obstructive hypertrophic cardiomyopathy (HC) are at increased risk of death or severe symptoms. Although metabolic exercise testing is routinely used in the evaluation of a variety of cardiac diseases, data on the prognostic information that can be derived from such testing in HC is lacking. We examined 182 patients (mean age 53 ± 15 years; 65% men) with obstructive HC and minimal or no cardiovascular symptoms. Each patient underwent maximum exercise testing with simultaneous metabolic gas exchange measurement. Follow-up (mean 4.0 ± 3.0 years; 100% complete) was performed to determine the vital status and occurrence of severe symptoms, defined as class III or IV symptoms of dyspnea or angina. Multiple parameters of metabolic exercise were associated with a risk of death and the development of severe symptoms. On multivariate analyses, the independent predictors of death and severe symptoms were the severity of the left ventricular outflow tract gradient at rest and the percentage of predicted peak myocardial oxygen consumption achieved during exercise. For patients with a percentage of predicted peak myocardial oxygen consumption of <60%, the 4-year survival rate free of death and severe symptoms was only 59%. In conclusion, among patients with obstructive HC and mild or no symptoms, a low metabolic exercise capacity is associated with an increased risk of death and the subsequent development of severe symptoms.
Asunto(s)
Cardiomiopatía Hipertrófica/diagnóstico , Metabolismo Energético/fisiología , Prueba de Esfuerzo/estadística & datos numéricos , Ejercicio Físico/fisiología , Consumo de Oxígeno/fisiología , Obstrucción del Flujo Ventricular Externo/complicaciones , Cardiomiopatía Hipertrófica/etiología , Cardiomiopatía Hipertrófica/metabolismo , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Reproducibilidad de los Resultados , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Obstrucción del Flujo Ventricular Externo/metabolismo , Obstrucción del Flujo Ventricular Externo/fisiopatologíaRESUMEN
The right ventricle (RV) differs in several aspects from the left ventricle (LV) including its embryonic origin, physiological role and anatomical design. In contrast to LV hypertrophy, little is known about the molecular circuits, which are activated upon RV hypertrophy (RVH). We established a highly reproducible model of RVH in mice using pulmonary artery clipping (PAC), which avoids detrimental RV pressure overload and thus allows long-term survival of operated mice. Magnetic resonance imaging revealed pathognomonic changes with striking similarities to human congenital heart disease- or pulmonary arterial hypertension-patients. Comparative, microarray based transcriptome analysis of right- and left-ventricular remodeling identified distinct transcriptional responses to pressure-induced hypertrophy of either ventricle, which were mainly characterized by stronger transcriptional responses of the RV compared to the LV myocardium. Hierarchic cluster analysis revealed a RV- and LV-specific pattern of gene activity after induction of hypertrophy, however, we did not find evidence for qualitatively distinct regulatory pathways in RV compared to LV. Data mining of nearly three thousand RV-enriched genes under PAC disclosed novel potential (co)-regulators of long-term RV remodeling and hypertrophy. We reason that specific inhibitory mechanisms in RV restrict excessive myocardial hypertrophy and thereby contribute to its vulnerability to pressure overload.
Asunto(s)
Obstrucción del Flujo Ventricular Externo/metabolismo , Obstrucción del Flujo Ventricular Externo/fisiopatología , Animales , Análisis por Conglomerados , Hipertrofia Ventricular Derecha/metabolismo , Hipertrofia Ventricular Derecha/patología , Hipertrofia Ventricular Derecha/fisiopatología , Imagen por Resonancia Magnética , Masculino , Ratones , Ratones Endogámicos C57BL , Análisis de Secuencia por Matrices de Oligonucleótidos , Obstrucción del Flujo Ventricular Externo/patologíaRESUMEN
Previous studies have shown that Foxc1 and Foxc2, closely related Fox transcription factors, have interactive roles in cardiovascular development. However, little is known about their functional overlap during early heart morphogenesis. Here, we show that Foxc genes are coexpressed in a novel heart field, the second heart field, as well as the cardiac neural crest cells (NCCs), endocardium, and proepicardium. Notably, compound Foxc1; Foxc2 mutants have a wide spectrum of cardiac abnormalities, including hypoplasia or lack of the outflow tract (OFT) and right ventricle as well as the inflow tract, dysplasia of the OFT and atrioventricular cushions, and abnormal formation of the epicardium, in a dose-dependent manner. Most importantly, in the second heart field, compound mutants exhibit significant downregulation of Tbx1 and Fgf8/10 and a reduction in cell proliferation. Moreover, NCCs in compound mutants show extensive apoptosis during migration, leading to a failure of the OFT septation. Taken together, our results demonstrate that Foxc1 and Foxc2 play pivotal roles in the early processes of heart development, especially acting upstream of the Tbx1-FGF cascade during the morphogenesis of the OFT.
Asunto(s)
Factores de Transcripción Forkhead/fisiología , Corazón/embriología , Animales , Linaje de la Célula/genética , Linaje de la Célula/fisiología , Femenino , Factores de Crecimiento de Fibroblastos/fisiología , Factores de Transcripción Forkhead/deficiencia , Factores de Transcripción Forkhead/genética , Corazón/fisiopatología , Ventrículos Cardíacos/embriología , Ventrículos Cardíacos/metabolismo , Ventrículos Cardíacos/fisiopatología , Ratones , Ratones Noqueados , Mutación , Proteínas de Dominio T Box/fisiología , Obstrucción del Flujo Ventricular Externo/embriología , Obstrucción del Flujo Ventricular Externo/genética , Obstrucción del Flujo Ventricular Externo/metabolismoRESUMEN
The objective of this study was to evaluate the potential role of B-type natriuretic peptide (BNP) levels in children with congenital heart disease undergoing cardiac catheterization. Measurement of plasma BNP concentration has been shown to be useful in the diagnosis, risk stratification, and management of adult patients with congestive heart failure, but little is known about the role of BNP in children with structural congenital heart disease. We measured plasma BNP levels using the Triage BNP test in patients with congenital heart disease referred for diagnostic or interventional cardiac catheterization. Plasma BNP concentration was measured in 96 children and 11 adults > or = 19 years old (7.9+/-8.3 years) undergoing heart catheterization for underlying congenital heart disease. BNP levels ranged from < 5 to > 1300 pg/ml, with a median BNP concentration of 19.0 pg/ml. Baseline BNP concentrations were > 100.0 pg/ml on 19 occasions in 17 patients. The pressure difference between the left ventricle and ascending aorta was 10-110 mmHg in 21 patients. BNP concentrations for this cohort ranged from < 5.0 to 1060.0 pg/ml and correlated with the degree of left ventricular outflow obstruction (correlation coefficient, 0.661; p = 0.001). This study suggests that with additional research, BNP concentration may prove to be a useful clinical tool in managing children and adults with congenital heart disease.
Asunto(s)
Cardiopatías Congénitas/metabolismo , Péptido Natriurético Encefálico/metabolismo , Adolescente , Adulto , Factores de Edad , Cateterismo , Niño , Preescolar , Femenino , Atrios Cardíacos/metabolismo , Atrios Cardíacos/fisiopatología , Atrios Cardíacos/cirugía , Cardiopatías Congénitas/fisiopatología , Cardiopatías Congénitas/terapia , Defectos del Tabique Interatrial/metabolismo , Defectos del Tabique Interatrial/fisiopatología , Defectos del Tabique Interatrial/terapia , Trasplante de Corazón , Ventrículos Cardíacos/metabolismo , Ventrículos Cardíacos/fisiopatología , Ventrículos Cardíacos/cirugía , Humanos , Lactante , Recién Nacido , Masculino , Contracción Miocárdica/fisiología , Presión Esfenoidal Pulmonar/fisiología , Estadística como Asunto , Resultado del Tratamiento , Obstrucción del Flujo Ventricular Externo/metabolismo , Obstrucción del Flujo Ventricular Externo/fisiopatología , Obstrucción del Flujo Ventricular Externo/terapiaRESUMEN
BACKGROUND: Children with cyanotic congenital heart disease and pulmonary outflow tract obstruction have shortened platelet survival times and are susceptible to thrombosis and organ infarction. Thromboxane A2 and prostacyclin have opposing actions on platelet aggregability and an imbalance in their biosynthesis might contribute to the pathophysiology of these complications. METHODS: Biosynthesis of thromboxane A2 and prostacyclin was investigated in 16 children (4-32 months, median 18 months) with cyanotic congenital heart disease and pulmonary outflow tract obstruction and compared with 16 healthy children of a similar age (6-34 months, median 24 months). Urinary excretion of 2,3-dinor-thromboxane B2 (a metabolite of thromboxane A2) and of 2,3-dinor-6-oxo-prostaglandin F1 alpha (a metabolite of prostacyclin) was measured. RESULTS: The children with cyanotic congenital heart disease and pulmonary outflow tract obstruction excreted more 2,3-dinor-thromboxane B2 than the healthy children: 916(163) compared with 592(122) ng/g creatinine (mean(SEM); 2p = 0.014). The ratio of excretion of 2,3-dinor-thromboxane B2 to 2,3-dinor-prostaglandin F1 alpha was greater in the patients than in the healthy control group (2.38(0.28) v 1.3(0.22)) (2p = 0.002). CONCLUSION: The balance between biosynthesis of prostacyclin and of thromboxane A2 is abnormal in children with cyanotic congenital heart disease and pulmonary outflow tract obstruction and favours platelet aggregation and vasoconstriction.